Evidence map›Paper›PMID 37654211›Full record

ArticleMolecular medicine reports2023

[Retracted] NCTD elicits proapoptotic and antiglycolytic effects on colorectal cancer cells via modulation of Fam46c expression and inhibition of ERK1/2 signaling.

Shiqiang Zhang, Yun Yang, Yunwei Hua, Chen Hu, Yi Zhong

Abstract readRetraction Notice
In one paragraph

Article in Molecular medicine reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors.

Shiqiang ZhangShanghai university of Traditional chinese Medicine, Tongji university, Shanghai 200082, P.R. China.
Yun YangShanghai university of Traditional chinese Medicine, Tongji university, Shanghai 200082, P.R. China.
Yunwei HuaDepartment of Gastroenterology, Shanghai Traditional chinese Medicine-integrated Hospital, Tongji university, Shanghai 200082, P.R. China.
Chen HuSchool of life Sciences and Technology, Tongji university, Shanghai 200082, P.R. China.
Yi ZhongDepartment of oncology, Shanghai Traditional chinese Medicine-integrated Hospital, Tongji university, Shanghai 200082, P.R. China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Following the publication of this paper, it was drawn to the Editor's attention by a concerned reader that the GAPDH control western blotting data shown in Fig. 2C were strikingly similar to data appearing in different form in other articles written by different authors at different research institutes. Moreover, certain of the western blotting data shown internally within Fig. 4E and F appeared to be strikingly similar, even though the experiments portrayed in these Figure parts were intended to show the results obtained from different cell lines. Owing to the fact that the contentious data in the above article were already under consideration for publication, or had already been published, prior to its submission to Molecular Medicine Reports, and based on an overall lack in the confidence in the data, the Editor has decided that this paper should be retracted from the Journal. The authors were asked for an explanation to account for these concerns, but the Editorial Office did not receive a reply. The Editor apologizes to the readership for any inconvenience caused. [Molecular Medicine Reports 22: 774‑782, 2020; DOI: 10.3892/mmr.2020.11151].

Indexed as

erK1/2 signalingfamily-with-sequence-similarity-46cglycolysisnorcantharidinproapoptosis

Identifiers

PMID37654211
PMCPMC10502944

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.